RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 115.20
+4.80 (4.35%)
Apr 2, 2026, 4:08 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 84.21 billion as of April 2, 2026. Its market cap has increased by 466.20% in one year.
Market Cap
84.21B
Enterprise Value
83.96B
Revenue
3.62B
Ranking
n/a
PE Ratio
80.25
Stock Price
115.20
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 84.21B, an increase of 152.20%. That is a compound annual growth rate of 18.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 84.21B | 86.30% |
| Dec 31, 2025 | 45.20B | 222.75% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovent Biologics | 158.77B |
| WuXi Biologics | 144.73B |
| Akeso | 129.42B |
| Sichuan Kelun-Biotech Biopharmaceutical | 117.41B |
| Sino Biopharmaceutical | 113.10B |
| 3SBio | 63.39B |
| Biocytogen Pharmaceuticals (Beijing) | 45.98B |
| Shanghai Henlius Biotech | 41.63B |